This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...

Costa Mesa, California - February 20, 2026 - PRESSADVANTAGE - Zenapet, a pet wellness company focused on nutritional ...

Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo ® for intravenous administration in the treatment of moderate to severe SLE. If approved, a ...

The combination is the first immune checkpoint inhibitor-based regimen to show a survival benefit for patients with ...

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are ...

Feb 3 (Reuters) - AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an ...

Large Danish cohort study reassures, with some women appearing to have a survival benefit ...

- First trial participant treated with PTM-101, an investigational thin film formulation of paclitaxel placed directly over the tumor for continuous localized drug exposure - - Trial enrolling ...

The original ruling did not permanently bar the comptroller from auditing the events of October 7, but temporarily froze work on eight defined “core” audits while ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Health Canada has approved ...